A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
Clinical trial NCT00589706 · COMPLETED
Trial details
- NCT number
- NCT00589706
- Sponsor
- Drexel University College of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1985-01-01
- Primary completion
- 2012-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.